Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.07B P/E - EPS this Y 15.60% Ern Qtrly Grth -
Income -283.26M Forward P/E -3.75 EPS next Y -8.40% 50D Avg Chg -9.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 13.00%
Dividend N/A Price/Book 2.50 EPS next 5Y - 52W High Chg -36.00%
Recommedations 2.00 Quick Ratio 3.18 Shares Outstanding 221.32M 52W Low Chg 87.00%
Insider Own 9.06% ROA -29.44% Shares Float 129M Beta 1.61
Inst Own 84.69% ROE -72.00% Shares Shorted/Prior 26.72M/24.68M Price 5.59
Gross Margin - Profit Margin - Avg. Volume 1,267,908 Target Price 12.40
Oper. Margin - Earnings Date May 6 Volume 771,362 Change -2.44%
About Sana Biotechnology, Inc.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, B-cell-mediated autoimmune, and others. The company's product candidates include SC291 that is used as allogeneic cell therapies for hematologic malignancies; ARDENT for a potential treatment for non-Hodgkin's lymphoma, and chronic lymphoblastic leukemia; GLEAM, to treat multiple autoimmune disorders that involve production of autoimmune antibodies, including lupus nephritis, extrarenal lupus, antineutrophil cytoplasmic antibody -associated vasculitis, and others. It is developing SC262 to treat patients with relapsed and/or refractory B-cell malignancies; SC255 for multiple myeloma treatment; SC379, a therapy for patients with certain central nervous system disorders healthy allogeneic glial progenitor cells; SC451, a product candidate to treat diabetes, with an initial focus on type 1 diabetes mellitus; and UP421 that reduces long-term exogenous insulin dependence. The company has an option and license agreement with Beam Therapeutics Inc. for use of Beam's proprietary CRISPR Cas12b nuclease editing technology to research, develop, and commercialize engineered cell therapy products; and a license agreement with Harvard College to access certain intellectual property for the development of hypoimmune-modified cells. The company was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. Sana Biotechnology, Inc. was incorporated in 2018 and is headquartered in Seattle, Washington.

Sana Biotechnology, Inc. News
03/11/24 Director Patrick Yang Sells 25,000 Shares of Sana Biotechnology Inc (SANA)
03/07/24 Baillie Gifford Bolsters Stake in Sana Biotechnology Inc
02/29/24 Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
02/29/24 14 Stocks With Heavy Insider Buying In 2024
02/28/24 Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
02/19/24 Institutional investors are Sana Biotechnology, Inc.'s (NASDAQ:SANA) biggest bettors and were rewarded after last week's US$521m market cap gain
02/13/24 Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP
02/12/24 Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
02/08/24 Sana Biotechnology Announces Pricing of Upsized Public Offering
02/07/24 Sana Biotechnology Announces Proposed Public Offering of Common Stock
01/18/24 Are You Looking for a Top Momentum Pick? Why Sana Biotechnology (SANA) is a Great Choice
01/18/24 Sana Bio (SANA) Stock Rallies 105% in 3 Months: Here's Why
01/05/24 Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell Malignancies
01/03/24 Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/19/23 EVP Christian Hordo Sells 75,000 Shares of Sana Biotechnology Inc (SANA)
12/11/23 Sana Biotechnology Highlights Preclinical Data Supporting Tumor Control and Immune Evasion Capabilities of Hypoimmune-Modified Allogeneic CAR T Cells in Presentations at the American Society of Hematology Annual Meeting
12/01/23 Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System
11/21/23 Sana Biotechnology to Present at November and December 2023 Investor Conferences
11/21/23 Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
11/17/23 Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes
SANA Chatroom

User Image jmlin1 Posted - 4 hours ago

$SANA This stock has bad habit of dipping down on the late afternoon.

User Image Doozio Posted - 1 day ago

$SANA chop chop huckleberries again in 🧠⏰♾️

User Image jmlin1 Posted - 1 day ago

$SANA good support

User Image vu_jade Posted - 04/29/24

$SANA LfG

User Image TreDogg Posted - 04/25/24

$SANA

User Image vu_jade Posted - 04/23/24

$SANA like the reversal

User Image JerryMalone32 Posted - 04/23/24

@Rhatter @Jjpratt19 did biogen have any issues following Williams' departure from biogen to $sana? Was it "game over" for $biib too? ROFLMAO

User Image dixiebull Posted - 04/22/24

$SANA tags 8 I like it

User Image HarryWanger Posted - 04/22/24

$SANA Look out below!! "Sana Biotechnology R&D leader Douglas Williams steps down" Always an awful sign. Look for more execs jumping ship soon. Game. Over!

User Image JRNY13 Posted - 04/19/24

$SANA down 15% this week

User Image torabisu Posted - 04/18/24

$SANA wtf!?

User Image TreDogg Posted - 04/16/24

$SANA

User Image Djabb8073 Posted - 04/08/24

$SANA let’s goo fooool

User Image Djabb8073 Posted - 04/04/24

$SANA I’m in 300 shares @9.10 How’s urrbody feeling about this!?

User Image jmlin1 Posted - 1 month ago

$SANA It is over reacting. Please calm down.

User Image vu_jade Posted - 1 month ago

$SANA looks ready to fly

User Image waterlock Posted - 1 month ago

TOP 3 $MGTX $SANA $WVE typo

User Image waterlock Posted - 1 month ago

$KALV WTF?!!? I did not notice this. They have closed 150M USD at ~$15. I thought their stock price went to so did not completed he fundraising. Well, now it is a huge buy for me. ================= Also in February, KalVista closed an underwritten offering to sell an aggregate of 7,016,312 shares of common stock at price of $15.25 per share and pre-funded warrants to purchase up to 3,483,688 shares of common stock at a price of $15.249 per pre-funded warrant. Top 3 holding: $MGTX $SANA $KALV

User Image jmlin1 Posted - 1 month ago

$SANA May 10, 2024

User Image maverickov Posted - 03/27/24

$sana is more than %128 from my alert

User Image JerryMalone32 Posted - 03/27/24

@spderman @Fatpocketz Thanks for the well wishes. I care more about $grts and $sana at this point than $blue. If $grts data is good (its data will be released today, tomorrow or monday), then it will be bought out this summer and I can use $blue (and $tsvt for that matter) as tax loss harvesting (ha ha).

User Image Walter4483 Posted - 03/26/24

$SANA could this go parabolic soon?

User Image JerryMalone32 Posted - 03/21/24

@scanningforbiotechstocks $grts Gritstone Bio. $sana Sana Biotechnology would be 2 others.

User Image idirmo Posted - 03/12/24

$SANA just keep buying, it's time to add some shares next target 16$.

User Image jmlin1 Posted - 03/11/24

$SANA Insider traded last Friday. Peaking for now.

User Image jmlin1 Posted - 03/07/24

$SANA Without any news, it wouldn't move.

User Image BriOnH Posted - 03/07/24

@crabbypatty31 @Dontlistentome423 @JimmyO3535 I am more focused on investing in stocks that show promise in finding a cure, but will swing on podd and dxcm still. $SANA has a really interesting trial this year with hypoallergenic islets in humans that I am excited to see.

User Image _www_larval_com_ Posted - 03/06/24

$SANA has turned 3% higher to -2% (~2Mv) in the last few minutes, 03/15 options, follow for more volatility.

User Image waterlock Posted - 03/06/24

$SANA There are plenty rooms for SANA to manipulate their financial statements. They have made the licensing simply too complicated. There will be huge amount of dilution occur in the following quarters. I don't like this financial profile. My experience is that this type of complex will lead to failure.

User Image waterlock Posted - 03/05/24

$SANA They have issued pre-funded warrants (huge amount). What is the exercise price though? couldn't find it anywhere in the S-3 form and in the PR.

Analyst Ratings
JMP Securities Market Outperform Mar 1, 24
HC Wainwright & Co. Buy Mar 1, 24
HC Wainwright & Co. Buy Jan 16, 24
JMP Securities Market Outperform Oct 12, 23
JMP Securities Market Outperform Sep 25, 23
Citigroup Buy Sep 5, 23
TD Cowen Market Perform Aug 14, 23
HC Wainwright & Co. Neutral May 2, 23
Morgan Stanley Overweight Jan 24, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Flagship Ventures Fund V Gener... 10% Owner 10% Owner Jun 06 Sell 6.27 403,758 2,531,563 1,380,277 06/08/23
Flagship Ventures Fund V Gener... 10% Owner 10% Owner May 24 Sell 6.38 545,242 3,478,644 1,425,334 05/26/23
MacDonald James J. EVP & General Counse.. EVP & General Counsel Jun 13 Option 1.48 66,796 98,858 497,396 06/15/22
Yang Patrick Y Director Director Mar 21 Buy 7.30 28,000 204,400 174,250 03/22/22
MacDonald James J. EVP & General Counse.. EVP & General Counsel Feb 18 Sell 6.28 333 2,091 429,417 02/23/22
Hordo Christian EVP, Chief Business.. EVP, Chief Business Officer Sep 10 Sell 25.01 64,671 1,617,422 943,932 09/10/21
Hordo Christian EVP, Chief Business.. EVP, Chief Business Officer Sep 10 Option 1.48 39,205 58,023 1,008,603 09/10/21
Hordo Christian EVP, Chief Business.. EVP, Chief Business Officer Sep 07 Sell 25 8,658 216,450 969,398 09/07/21
Hordo Christian EVP, Chief Business.. EVP, Chief Business Officer Sep 07 Option 1.48 7,258 10,742 970,098 09/07/21